DENTSPLY SIRONA

DENTSPLY SIRONA is a manufacturer of dental products and technologies. The company's Consumables segment is responsible for the design, manufacture, sales and distribution of the company's dental consumable products which include preventive, restorative, endodontic, and dental laboratory products. The company's Technologies and Equipment segment includes responsibility for the design, manufacture, sales and distribution of the company's dental technology and equipment products and healthcare consumable products, including dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, and consumable medical device products.
  • TickerXRAY
  • ISINUS24906P1093
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Dentsply Sirona Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Dentsply Sirona Inc.: Update to credit analysis

Our credit view of this issuer reflects its strong market position in the dental device industry, offset by the somewhat cyclical nature of procedures and a growth strategy that has included

With a more favourable environment, DENTSPLY SIRONA improves to Slightly Positive

DENTSPLY SIRONA (US), a company active in the Medical Equipment industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date May 11, 2021, the closing price was USD 66.80 and its potential was estimated at USD 75.98.

Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc.. Global Credit Research- 09 Apr 2021. New York, April 09, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • The U.S. dollar is breaking its 16-month uptrend and is declining through its 200-day moving average and Gold is breaking to 6-year price highs. RS appears to be staging a reversal at a support level. (ex. GC00, GDX) • A number of Healthcare Sector names are breaking out or staging reversals. (ex. ITGR, CHE, XRAY, OMCL, MOH, WCG, ARWR, INCY, GILD, VRTX, IQV, MEDP, and CTLT)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Gold appears to be developing a potential head-and-shoulders bottom. A break above the $128 level would be very bullish. (ex. GLD and GDX) • A number of restaurants are bullishly inflecting, trending up and to the right. (ex. JACK, DIN, SHAK, and YUM) • REIT's continue to be leadership (ex. PSB, HCP, HR, WELL, ARE, ESS, MAA, AMT, CCI, and SBAC)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Health Care Equipment & Supplies remains a leadership area in the Health Care Sector. • A number of Biotechnology stocks are making major reversals with many hitting 52-week RS highs. • Semiconductors, Semi-Suppliers, and Electronic Components remain as leadership Groups.

DENTSPLY Sirona Inc: 1 director bought

A director at DENTSPLY Sirona Inc bought 5,000 shares at 58.950USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of...

Jonathan Moreland

InsiderInsights Daily Ratings Report: March 4, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland

InsiderInsights Daily Ratings Report: March 4, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

MarketLine Department

Zimmer Biomet Holdings Inc. - Strategy, SWOT and Corporate Finance Report

Summary Zimmer Biomet Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Zimmer Biomet Holdings Inc. (Zimmer Biomet or 'the company') is a designer, manufacturer and marketer of medical devices. The company offers sports medicine, orthopaedic reconstructive products, extremities, spine, biologics and trauma products, craniomaxillofacial and thoracic p...

MarketLine Department

Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report

Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Align Technology, Inc. (AlignTech or 'the company') is a medical device company that designs and manufactures clear aligners and intra-oral scanners and services for dentistry, orthodontics, and dental records storage. The company's product portfolio comprises Invisalign clear aligner...

MarketLine Department

Align Technology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Align Technology, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Align Technology, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive adva...

Dentsply Sirona Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Dentsply Sirona Inc.: Update to credit analysis

Our credit view of this issuer reflects its strong market position in the dental device industry, offset by the somewhat cyclical nature of procedures and a growth strategy that has included

Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc.. Global Credit Research- 09 Apr 2021. New York, April 09, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit.

Moody's says Dentsply Sirona's acquisition of Byte has no rating impact

Announcement: Moody's says Dentsply Sirona's acquisition of Byte has no rating impact. Global Credit Research- 04 Jan 2021. New York, January 04, 2021-- Moody's Investors Service, commented that Dentsply Sirona Inc'. s acquisition of Byte, while strategically sensible, is credit negative as the company used approximately $1.04 billion of cash to fund the acquisition.

Dentsply Sirona Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

With a more favourable environment, DENTSPLY SIRONA improves to Slightly Positive

DENTSPLY SIRONA (US), a company active in the Medical Equipment industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date May 11, 2021, the closing price was USD 66.80 and its potential was estimated at USD 75.98.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch